Table 1.
Properties of GAS clinical isolates and effects of GAS exposure on DC phenotype.
iDC | Group I isolates | Group II isolates | Group III isolates | |
---|---|---|---|---|
GAS Phenotype | ||||
No. of isolates | 6 | 3 | 15 | |
HA (fg/CFU) | 13.6 ± 7.6 | 50.2 ± 17.2 | 4.9 ± 3.0 | |
SLO (HU) | 1.8 ± 0.3 | 21.6 ± 13.2 | 20.2 ± 5.5 | |
DC Phenotype | ||||
CD83 (MFI) | 2.3 ± 1.1 | 10.3 ± 0.4 | 2.9 ± 0.4 | 1.8 ± 0.2 |
HLA-DR (MFI) | 14.4 ± 0.7 | 23.5 ± 1.1 | 14.3 ± 1.4 | 7.5 ± 0.4 |
CD80 (MFI) | 18.6 ± 0.3 | 50.7 ± 5.2 | 17.1 ± 3.1 | 3.7 ± 0.4 |
Hypodiploid DC (%) | 5.9 ± 1.1 | 8.3 ± 0.8 | 10.5 ± 3.0 | 58.4 ± 2.0 |
DC with associated GAS (%) | 74.0 ± 6.5 | 21.8 ± 9.1 | 90.6 ± 1.0 |
Note.- iDC = Untreated DC; MFI = Median Fluorescence Intensity; HU = Hemolytic Units. Values reported correspond to group means±SD.